Form 4: Y-mAbs Therapeutics SVP Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Vignesh Rajah, SVP & Chief Medical Officer of Y-mAbs Therapeutics, sold 1,711 shares of common stock on March 5, 2024, to cover tax liabilities associated with vesting restricted stock units.
Summary
- On March 5, 2024, Vignesh Rajah, the SVP & Chief Medical Officer of Y-mAbs Therapeutics, sold 1,711 shares of common stock.
- The sale was executed to cover tax liabilities related to the vesting and settlement of restricted stock units.
- The shares were sold at a weighted average price of $16.53, with individual trades ranging from $16.52 to $16.555.
- Following the transaction, Rajah directly owns 33,889 shares of Y-mAbs Therapeutics.
- Additionally, Rajah indirectly owns 4,266 shares through his spouse and minor child.
Sentiment
Score: 5
Explanation: The document describes a routine stock sale to cover tax obligations, which is neither particularly positive nor negative.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Date of the stock sale transaction. |
| 03/07/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.